The efficacy of PD‐1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study

Abstract Objective Immune checkpoint inhibitors (ICIs) have been considered as novel therapeutic approaches for various cancers. ICIs were reportedly efficacious against rare cancers, including salivary gland carcinoma (SGC). We aimed to analyze the efficacy and safety of ICIs in patients with SGC....

Full description

Bibliographic Details
Main Authors: Ryosuke Sato, Takumi Kumai, Yoshiya Ishida, Ryota Yuasa, Akinobu Kubota, Risa Wakisaka, Hiroki Komatsuda, Hidekiyo Yamaki, Tetsuji Wada, Yasuaki Harabuchi
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Laryngoscope Investigative Otolaryngology
Subjects:
Online Access:https://doi.org/10.1002/lio2.863